Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Citi
Daiichi Sankyo
Moodys
Medtronic
Federal Trade Commission
AstraZeneca
Teva

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062849

« Back to Dashboard

NDA 062849 describes BACITRACIN ZINC-POLYMYXIN B SULFATE, which is a drug marketed by Naska and is included in one NDA. Additional details are available on the BACITRACIN ZINC-POLYMYXIN B SULFATE profile page.

The generic ingredient in BACITRACIN ZINC-POLYMYXIN B SULFATE is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
Summary for 062849
Tradename:BACITRACIN ZINC-POLYMYXIN B SULFATE
Applicant:Naska
Ingredient:bacitracin zinc; polymyxin b sulfate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:OINTMENT;TOPICALStrength500 UNITS/GM;10,000 UNITS/GM
Approval Date:Nov 13, 1987TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Merck
McKinsey
Colorcon
Dow
Deloitte
Boehringer Ingelheim
Chinese Patent Office
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.